Pathogenesis of falciparum malaria in infancy
婴儿期恶性疟疾的发病机制
基本信息
- 批准号:6532906
- 负责人:
- 金额:$ 64.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2005-05-31
- 项目状态:已结题
- 来源:
- 关键词:African Plasmodium falciparum cell adhesion molecules chondroitin sulfates clinical research erythrocytes female genotype hemoglobin As hemoglobin F host organism interaction human pregnant subject human subject infant human (0-1 year) longitudinal human study malaria microorganism immunology molecular pathology pathologic process polymerase chain reaction pregnancy infection preschool child (1-5) protein binding receptor binding receptor expression surface antigens
项目摘要
DESCRIPTION (provided by the applicant): Malaria kills 1 million African
children each year. However, although all infants in holoendemic areas develop
parasitemia frequently, only 10 percent develop severe anemia, the commonest
cause of death. We previously showed that parasite adhesion and anti-adhesion
antibodies explain susceptibility and resistance to pregnancy malaria. Because
the parasites infecting children have binding phenotypes distinct from those
infecting adults, we hypothesize that a similar paradigm explains the
pathogenesis of infancy malaria.
We propose a longitudinal study of infants from birth through age 3. We will
examine samples for: 1) P. falciparum adhesion phenotype; 2) anti-adhesion
antibodies; 3) presence of parasites in hemoglobin (Hb)Fvs HbA-containing
(i.e., fetal vs. maternal) red cells; 4) levels of p-amino benzoic acid (PABA),
HbF, and antibodies. We will test our primary hypothesis that parasite binding
and anti-adhesion antibodies predict severe infancy malaria. In addition, we
will examine a secondary hypothesis that neonates are resistant to malaria
because their vasculature does not support parasite binding. Based on our
hypotheses, we expect the following results: 1) parasite adhesion phenotypes
change with host age; 2) anti-adhesion antibodies protect infants from
parasites with the corresponding adhesion phenotype; 3) parasite binding
patterns and specific anti-adhesion antibodies predict protection from severe
anemia; 4) cord blood parasites will bind CSA, and parasites will appear
exclusively in HbA-containing red cells of neonates; 5) the genotype and
binding phenotype will differ between cord blood isolates and isolates obtained
at the time of an infant's first infection.
We will examine other factors for their effect on malaria, including
transpiacentally transferred maternal antibodies, HbF, and PABA levels, and we
will determine HIV status as a potential confounder in these studies. If
breastfeeding confers resistance to malaria by limiting PABA intake, this will
influence the debate on whether HIV-infected women in tropical areas should
breastteed. These studies will establish the roles of parasite adhesion and
anti-adhesion antibodies in the pathogenesis of infancy malaria, and may
identify new targets for antimalarial therapies in children. Identifying new
therapies for children is an urgent public health goal, but is not a funding
priority for the United States Department of Defense.
描述(由申请人提供):疟疾导致100万非洲人死亡
每年都有孩子。然而,尽管全流行地区的所有婴儿都发育
寄生虫血症频繁,只有10%患上严重贫血,最常见
死因是。我们之前证明了寄生虫的黏附和抗黏附
抗体解释了对妊娠疟疾的易感性和抵抗力。因为
感染儿童的寄生虫具有不同于
感染成人,我们假设类似的范式解释了
婴幼儿疟疾的发病机制。
我们建议对婴儿从出生到3岁进行纵向研究。
检测样本:1)恶性疟原虫黏附表型;2)抗黏附
抗体;3)含HBA的血红蛋白(Hb)抗体中寄生虫的存在
(即胎儿与母体)红细胞;4)对氨基苯甲酸(PABA)水平,
HBF和抗体。我们将测试我们最初的假设,即寄生虫结合
抗黏附抗体可以预测严重的婴儿期疟疾。此外,我们
将检验第二个假设,即新生儿对疟疾具有抵抗力
因为它们的血管系统不支持寄生虫结合。基于我们的
假设,我们期望得到以下结果:1)寄生虫黏附表型
随宿主年龄变化;2)抗黏附抗体保护婴儿免受
具有相应黏附表型的寄生虫;3)寄生虫结合
模式和特异性抗黏附抗体可预测对重症
4)脐带血寄生虫会与CsA结合,从而出现寄生虫
仅在新生儿含HBA的红细胞中;5)基因和
脐带血分离株和获得的分离株的结合表型不同
在婴儿第一次感染时。
我们将研究它们对疟疾产生影响的其他因素,包括
经皮转移的母体抗体、HBF和PABA水平,以及我们
将在这些研究中将艾滋病毒状况确定为一个潜在的混杂因素。如果
母乳喂养通过限制PABA的摄入量来增强对疟疾的抵抗力
影响热带地区感染艾滋病毒的妇女是否应该
戴着胸罩。这些研究将确定寄生虫黏附和
抗黏附抗体在婴幼儿疟疾发病机制中的作用
确定儿童抗疟疾治疗的新靶点。确定新的
儿童治疗是一项紧迫的公共卫生目标,但不是一项资金
美国国防部的优先事项。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PATRICK E DUFFY其他文献
PATRICK E DUFFY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PATRICK E DUFFY', 18)}}的其他基金
PfSPZ Challenge with Chemoprophylaxis: Phase 1 Trial to Assess Liver Stage Drug
PfSPZ 化学预防挑战:评估肝期药物的 1 期试验
- 批准号:
8639832 - 财政年份:2013
- 资助金额:
$ 64.21万 - 项目类别:
PfSPZ Challenge with Chemoprophylaxis: Phase 1 Trial to Assess Liver Stage Drug
PfSPZ 化学预防挑战:评估肝期药物的 1 期试验
- 批准号:
8904590 - 财政年份:2013
- 资助金额:
$ 64.21万 - 项目类别:
PfSPZ Challenge with Chemoprophylaxis: Phase 1 Trial to Assess Liver Stage Drug
PfSPZ 化学预防挑战:评估肝期药物的 1 期试验
- 批准号:
8728730 - 财政年份:2013
- 资助金额:
$ 64.21万 - 项目类别:
Effect of IPTP Regimens on Malaria-Related Immunity
IPTP 方案对疟疾相关免疫的影响
- 批准号:
6969064 - 财政年份:2005
- 资助金额:
$ 64.21万 - 项目类别:
Preventing Pregnancy Malaria: Maternal-Infant Outcomes
预防妊娠疟疾:母婴结局
- 批准号:
7278225 - 财政年份:2005
- 资助金额:
$ 64.21万 - 项目类别:
Preventing Pregnancy Malaria: Maternal-Infant Outcomes
预防妊娠疟疾:母婴结局
- 批准号:
7491577 - 财政年份:2005
- 资助金额:
$ 64.21万 - 项目类别:
Preventing Pregnancy Malaria: Maternal-Infant Outcomes
预防妊娠疟疾:母婴结局
- 批准号:
7120009 - 财政年份:2005
- 资助金额:
$ 64.21万 - 项目类别:
Preventing Pregnancy Malaria: Maternal-Infant Outcomes
预防妊娠疟疾:母婴结局
- 批准号:
6960211 - 财政年份:2005
- 资助金额:
$ 64.21万 - 项目类别:
相似海外基金
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
消灭前环境中恶性疟原虫疟疾的基因组学和血清流行病学
- 批准号:
10666280 - 财政年份:2023
- 资助金额:
$ 64.21万 - 项目类别:
Elucidating mechanisms for artemisinin-induced dormancy in Plasmodium falciparum
阐明青蒿素诱导恶性疟原虫休眠的机制
- 批准号:
10742385 - 财政年份:2023
- 资助金额:
$ 64.21万 - 项目类别:
Investigating the role of SCF ubiquitin ligases during sexual development of Plasmodium falciparum
研究 SCF 泛素连接酶在恶性疟原虫性发育过程中的作用
- 批准号:
MR/W025566/1 - 财政年份:2023
- 资助金额:
$ 64.21万 - 项目类别:
Research Grant
Rotation 1: Investigating the role(s) of the putative FANCJ helicase in the malaria parasite Plasmodium falciparum
第 1 轮:研究假定的 FANCJ 解旋酶在疟原虫恶性疟原虫中的作用
- 批准号:
2886902 - 财政年份:2023
- 资助金额:
$ 64.21万 - 项目类别:
Studentship
Exploring the role of phosphoinositides in the trafficking of proteins to the apical complex in the malaria parasite Plasmodium falciparum.
探索磷酸肌醇在疟原虫恶性疟原虫顶复合体蛋白质运输中的作用。
- 批准号:
495093 - 财政年份:2023
- 资助金额:
$ 64.21万 - 项目类别:
Operating Grants
DDT-BMQ-0000100 Qualification of the Plasmodium falciparum 18S rRNA biomarker for malaria-endemic controlled human malaria infection studies
DDT-BMQ-0000100 疟疾流行控制人类疟疾感染研究中恶性疟原虫 18S rRNA 生物标志物的鉴定
- 批准号:
10836140 - 财政年份:2023
- 资助金额:
$ 64.21万 - 项目类别:
Defining molecular determinants of Plasmodium falciparum hematopoietic infection using single cell profiling and genetics
使用单细胞分析和遗传学定义恶性疟原虫造血系统感染的分子决定因素
- 批准号:
EP/Y003705/1 - 财政年份:2023
- 资助金额:
$ 64.21万 - 项目类别:
Fellowship
Detailed mechanism of trafficking proteins involved in the virulence of Plasmodium falciparum
恶性疟原虫毒力中涉及的运输蛋白的详细机制
- 批准号:
22KF0032 - 财政年份:2023
- 资助金额:
$ 64.21万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Étude du rôle de la phosphatase de phosphoinositides SAC1 dans le trafic de protéines au complexe apical chez le parasite de la malaria Plasmodium falciparum
疟疾疟原虫顶端寄生虫复合物中磷酸肌醇磷酸酶 SAC1 的研究
- 批准号:
486094 - 财政年份:2022
- 资助金额:
$ 64.21万 - 项目类别:
Studentship Programs
Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum
开发一种多成分疫苗,利用针对恶性疟原虫血液阶段的有效抗体和细胞反应
- 批准号:
10614511 - 财政年份:2022
- 资助金额:
$ 64.21万 - 项目类别: